Response to letter to editor 'comment on: Safinamide as adjunctive therapy for Parkinson's disease: A promising option with room for improvement'

被引：0
|
作者：
Nishikawa, Noriko [1 ]
Ishida, Takayuki [2 ]
Hatano, Taku [1 ]
Hattori, Nobutaka [1 ]
机构：
[1] Juntendo Univ, Fac Med, Dept Neurol, 2-1-1 Hongo,Bunkyo Ku, Tokyo 1138421, Japan
[2] Eisai & Co Ltd, Med HQs, 4-6-10 Koishikawa,Bunkyo Ku, Tokyo 1128088, Japan
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2024年 / 462卷
关键词：
Safinamide; Observational study; Patient-reported outcome; Clinical practice; ADD-ON; EFFICACY; LEVODOPA; SAFETY;
D O I：
10.1016/j.jns.2024.123101
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 34 条
  • [1] Comment on: Safinamide as adjunctive therapy for Parkinson's disease: A promising option with room for improvement
    Matovu, Daniel
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 462
  • [2] Emerging approaches in Parkinson's disease - adjunctive role of safinamide
    Mueller, Thomas
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1151 - 1160
  • [3] Collective Expert Perspectives on the Use of Safinamide as Adjunctive Therapy for Parkinson's Disease: Online-Based Delphi Survey
    Takeda, Atsushi
    Tsuboi, Yoshio
    Nomoto, Masahiro
    Mochizuki, Hideki
    Hattori, Nobutaka
    PARKINSONS DISEASE, 2022, 2022
  • [4] Safinamide as an adjunct therapy in older patients with Parkinson's disease: a retrospective study
    Lo Monaco, Maria Rita
    Petracca, Martina
    Vetrano, Davide Liborio
    Di Stasio, Enrico
    Fusco, Domenico
    Ricciardi, Diego
    Laudisio, Alice
    Zuccala, Giuseppe
    Onder, Graziano
    Bentivoglio, Anna Rita
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2020, 32 (07) : 1369 - 1373
  • [5] Safinamide as adjunctive therapy to levodopa monotherapy for patients with Parkinson's disease with wearing-off: The Japanese observational J-SILVER study
    Nishikawa, Noriko
    Hatano, Taku
    Nishioka, Kenya
    Ueno, Shin-Ichi
    Saiki, Shinji
    Nakamura, Ryota
    Yoritaka, Asako
    Ogawa, Takashi
    Shimo, Yasushi
    Sako, Wataru
    Shimura, Hideki
    Furukawa, Yoshiaki
    Kamei, Takanori
    Ishida, Takayuki
    Hattori, Nobutaka
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 461
  • [6] Pain Improvement in Parkinson's Disease Patients Treated with Safinamide: Results from the SAFINONMOTOR Study
    Santos Garcia, Diego
    Yanez Bana, Rosa
    Labandeira Guerra, Carmen
    Cimas Hernando, Maria Iciar
    Cabo Lopez, Iria
    Paz Gonzalez, Jose Manuel
    Alonso Losada, Maria Gema
    Gonzalez Palmas, Maria Jose
    Cores Bartolome, Carlos
    Martinez Miro, Cristina
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):
  • [7] Current status of safinamide for the drug portfolio of Parkinson's disease therapy
    Mueller, Thomas
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (09) : 969 - 977
  • [8] Rasagiline and safinamide as a dopamine-sparing therapy for Parkinson's disease
    Avila, Asuncion
    Caballol, Nuria
    Martin-Baranera, Montserrat
    Gomez-Ruiz, Isabel
    Balague-Marmana, Marta
    Planas-Ballve, Anna
    Cardona, Xavier
    ACTA NEUROLOGICA SCANDINAVICA, 2019, 140 (01): : 23 - 31
  • [9] Sustained response in early responders to safinamide in patients with Parkinson's disease and motor fluctuations: A post hoc analysis of the SETTLE study
    Bhidayasiri, Roongroj
    Koebis, Michinori
    Kamei, Takanori
    Ishida, Takayuki
    Suzuki, Ippei
    Cho, Jin Whan
    Wu, Shey-Lin
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [10] Safinamide as an adjunct therapy in older patients with Parkinson’s disease: a retrospective study
    Maria Rita Lo Monaco
    Martina Petracca
    Davide Liborio Vetrano
    Enrico Di Stasio
    Domenico Fusco
    Diego Ricciardi
    Alice Laudisio
    Giuseppe Zuccalà
    Graziano Onder
    Anna Rita Bentivoglio
    Aging Clinical and Experimental Research, 2020, 32 : 1369 - 1373
1234